January 8, 2021
January 26, 2021
This week’s newsletter includes Clene Nanomedicine’s merger with Tottenham Acquisition I Limited, coverage of early vaccination for life sciences employees, early-bird registration for the 2021 virtual Entrepreneur & Investor Summit, Myriad Genetics’ completion of its strategic business unit and products review, upcoming virtual industry events, and more.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
